{"clarifying_information": [{"clarifying_question1": "Are you interested in the comparative advantages and drawbacks of cleavable versus non-cleavable ADC linkers for specific payloads or indications?", "clarifying_answer1": {"clarifying_answer": "Yes, I am interested in understanding the comparative advantages and drawbacks of cleavable versus non-cleavable ADC linkers, particularly as they relate to specific cytotoxic payloads or therapeutic indications."}}, {"clarifying_question2": "Do you want detailed information about the chemical conjugation strategies (such as lysine, cysteine, site-specific, click, or enzymatic conjugation) used to attach linkers to antibodies in ADCs?", "clarifying_answer2": {"clarifying_answer": "Yes, I would like detailed information about the chemical conjugation strategies, including lysine, cysteine, site-specific, click, and enzymatic conjugation, used to attach linkers to antibodies in ADCs."}}, {"clarifying_question3": "Are you seeking recent innovations in linker chemistries, such as stimuli-responsive or multiloading linkers, and how these affect ADC pharmacokinetics and therapeutic efficacy?", "clarifying_answer3": {"clarifying_answer": "Yes, I am particularly interested in recent innovations such as stimuli-responsive (e.g., redox, pH, enzyme, or light-activated) and multiloading/branched linkers, and would like to know how these new chemistries influence ADC pharmacokinetics, stability, therapeutic window, and efficacy."}}], "better_queries_2": {"reformulated1": "What are the comparative advantages and drawbacks of cleavable versus non-cleavable antibody-drug conjugate (ADC) linkers for different cytotoxic payloads and therapeutic indications?", "reformulated2": "What are the key chemical conjugation strategies\u2014such as lysine-based, cysteine-based, site-specific, click chemistry, and enzymatic methods\u2014for attaching linkers to antibodies in ADCs, and how do these approaches affect the resulting conjugate's homogeneity and pharmacological properties?", "reformulated3": "What recent innovations in ADC linker chemistries\u2014such as stimuli-responsive (e.g., redox, pH, enzyme, light-activated) and multiloading or branched linkers\u2014have emerged, and how do these advances impact ADC pharmacokinetics, stability, therapeutic index, and efficacy?"}}
